BMSC-Derived Exosomes Attenuate Rat Osteoarthritis by Regulating Macrophage Polarization through PINK1/Parkin

Beibei Li1, Enpu Shen2, Zhiwen Wu1

  • 1Department of Orthopaedics, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Cartilage
|April 20, 2024
PubMed

Insights

Bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exos) alleviate osteoarthritis by shifting synovial macrophage polarization. This mechanism involves inhibiting the PINK1/Parkin signaling pathway, offering a novel therapeutic strategy for OA.

Area of Science:

  • Stem cell biology
  • Immunology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is characterized by chronic inflammation and cartilage degradation.
  • Macrophage polarization, particularly the shift towards M1 pro-inflammatory phenotypes, plays a critical role in OA pathogenesis.
  • Bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exos) have shown therapeutic potential, but their precise mechanisms in OA, especially regarding macrophage polarization, remain unclear.

Purpose of the Study:

  • To investigate the role of BMSC-Exos in modulating macrophage polarization in osteoarthritis.
  • To elucidate the underlying molecular mechanisms by which BMSC-Exos exert their effects on macrophages and OA progression.

Main Methods:

  • Exosomes were isolated from bone marrow mesenchymal stem cells (BMSC-Exos).
  • The effects of BMSC-Exos on RAW264.7 macrophage cell line were assessed, measuring reactive oxygen species (ROS) and key protein expression (Akt, PINK1, Parkin).
  • An osteoarthritis rat model was established, and histological analyses (H&E, safranin O-fast green), immunohistochemistry, immunofluorescence, and serum cytokine level measurements (IL-6, IL-1β, TNF-α, IL-10) were performed.

Main Results:

  • BMSC-Exos treatment reduced mitochondrial damage, ROS production, and PINK1/Parkin expression in vitro.
  • Akt phosphorylation was restored by BMSC-Exos under inflammatory conditions.
  • In OA rats, BMSC-Exos attenuated cartilage damage, inhibited M1 macrophage polarization, and promoted M2 polarization in the synovium.
  • Synovial PINK1/Parkin expression and serum pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) were decreased, while anti-inflammatory IL-10 increased.

Conclusions:

  • BMSC-Exos effectively ameliorate osteoarthritis development by regulating synovial macrophage polarization.
  • Inhibition of the PINK1/Parkin signaling pathway is identified as a key mechanism underlying the therapeutic effects of BMSC-Exos in OA.